| Literature DB >> 25514176 |
Yan-xiang Pan1, Qing Ye2, Wen-xia Shao3, Shi-qiang Shang1, Jian-hua Mao4, Ting Zhang5, Hong-qiang Shen1, Ning Zhao1.
Abstract
Henoch-Schonlein purpura (HSP) is the most common type of connective tissue diseases which increasingly occurs in children in recent years and its pathogenesis remains unclear. In order to explore the immune parameters and underlying pathogenesis mechanism of children with HSP, the study involved 1232 patients with HSP having different clinical symptoms and their laboratory indicators were evaluated. Th1/Th2 imbalance and overactivity of Th2 cells can cause increase in the synthesis and release of immunoglobulins in children with HSP. The number of red blood cells and white blood cells in urine was directly proportional to the level of IgA and inversely proportional to the level of serum complements (C3 and C4). Activation of these complements caused by immunoglobulin in patients with HSP plays an important role in renal injury. The urinary protein content in children with HSP along with proteinuria was positively correlated with IgE level, and IgE mediated type 1 hypersensitivity can cause increase in capillary permeability and weakened the charge barrier; hence, it could be considered as one of the causes of proteinuria in HSP. Additionally, the NK cells percentage was reduced and impaired immune function of NK cells were related to the immune injury of the digestive tract and kidney.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25514176 PMCID: PMC4267823 DOI: 10.1371/journal.pone.0115261
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
The levels of cytokine, T lymphocytes subset, B cell, NK cell, immunoglobulin, complement and CRP from HSP group and normal control group [Median (range)].
| Parameters | HSP group (n = 1232) | normal control group (n = 400) |
|
| Age (year) | 5.24(1.0→14.6) | 5.75(1.6→15.7) | 0.54 |
| IL-2 (pg/mL) | 2.2(1.0→17.4) | 5.5(2.7→7.8) | <0.01 |
| IL-4 (pg/mL) | 3.2(0.9→5.9) | 2.8(1.1→4.0) | 0.03 |
| IL-6 (pg/mL) | 3.6(1.0→1634.5) | 4.0(2.4→8.5) | 0.62 |
| IL-10 (pg/mL) | 2.6(1.0→80.6) | 2.4(1.3→7.2) | 0.40 |
| TNF-α (pg/mL) | 2.3(1.0→59.2) | 2.3(1.0→3.0) | 0.31 |
| INF-γ (pg/mL) | 5.1(1.0→89.9) | 4.9(3.8→7.8) | 0.36 |
| IgG (g/L) | 10.7(2.6→21.5) | 8.8(6.7→13.8) | <0.01 |
| IgA (g/L) | 2.0(0.6→7.5) | 1.1(0.6→2.1) | <0.01 |
| IgM (g/L) | 1.2(0.2→4.8) | 1.1(0.4→1.5) | 0.02 |
| C3 (g/L) | 1.2(0.3→2.2) | 1.3(0.2→1.5) | 0.12 |
| C4 (g/L) | 0.3(0.1→0.8) | 0.2(0.1→0.4) | <0.01 |
| IgE (IU/mL) | 69.1(4.3→3240.0) | 27.7(4.3→62.3) | <0.01 |
| CRP (mg/L) | 7.0(1.0→64.0) | 2.1(1.0→8.0) | <0.01 |
| CD3+ (% of positivity) | 60.3(7.9→84.6) | 66.5(58.3→72.7) | <0.01 |
| CD4+ (% of positivity) | 29.3(10.5→51.1) | 34.8(29.9→47.3) | <0.01 |
| CD8+ (% of positivity) | 22.6(12.1→27.0) | 22.5(16.3→32.1) | 0.46 |
| CD4+/CD8+ | 1.3(0.4→3.5) | 1.6(1.0→2.9) | <0.01 |
| CD20+ (% of positivity) | 23.0(6.4→51.9) | 17.0(15.3→19.7) | <0.01 |
| CD3−CD16+ CD56+ (% of positivity) | 7.7(2.1→22.5) | 17.2(13.5→23.1) | <0.01 |
Figure 1Age distribution of patients with HSP with different clinical symptoms.
The characteristic of clinical symptoms in HSP children.
| Characteristic | Number (percentage) |
|
| |
| skin rash | 1232 (100.00%) |
| Abdominal pain | 739 (59.98%) |
| Joint pain | 690 (56.01%) |
| hemafecia | 419 (34.01%) |
| hematuresis | 296 (24.03%) |
| proteinuria | 222 (180.02%) |
|
| |
| 2 kinds | 476 (38.63%) |
| 3 kinds | 440 (35.71%) |
| 4 kinds | 224 (18.18%) |
| 5 kinds | 76 (6.17%) |
| 6 kinds | 16 (1.31%) |
Figure 2T cell subsets, serum cytokines, and immunoglobulin levels in children with HSP with abdominal pain.
All these indicators are statistically significant P<0.05.
Figure 3T cell subsets, immunoglobulin, and complement levels in children with HSP with hemafecia or hematuresis.
All these indicators are statistically significant P<0.05.
Figure 4The proportion of CD3−CD16+CD56+ and CD20+ cells in patients with HSP with gastrointestinal or kidney injury.